CymaBay Therapeutics Inc. (CBAY) gained 6.22% or 0.77 to $13.15. It is approximately 1.09 million shares traded, which is 156.79% compare to the average total volume 697151. The market cap of CBAY is $772.81 million. The year to date change is 659.56%. The 52 week price range is from $4.25 to $15.59. Price of CBAY have changed -1.12% during last week. It have changed 16.14% over last month, -11.57% over last 3 months, 52.65% over last 6 months and 179.46% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBAY is 12.21. It is -7.15% below current price. The 200-day Moving Averages for CBAY is 10.42. It is -20.76% below current price. The 52-week High is 15.59. It is 18.56% from the current price. The 52-week Low is 4.25. It is -67.68% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CBAY is 4.67 on 2018-05-15. Short % to float is 5.04%. There are some statistics of CBAY. It is has market cap $772.81 million. The share outstanding is 58.77 million. The average volume is 697151. It has 118.90M cash and 14.31M in debt. The percent of top 15 Institution holding is 62.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBAY is -35.42%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBAY is -30.44%.